Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Modern Challenges in Infection Prevention: Encapsulated Organisms in the era of novel complement inhibitors.
Modern Challenges in Infection Prevention: Encapsulated Organisms in the era of novel complement inhibitors. Kidney international Al Jurdi, A., Kotton, C. N., Lafayette, R. 2025Abstract
Complement inhibitors are now approved for use in atypical HUS, IgA nephropathy and in C3 glomerulopathy. They are being studied widely in kidney disease, and more indications may soon arise. This review addresses an approach to preventing infectious complications, particularly encapsulated organism infections, and will hopefully serve as guidance for nephrologists utilizing these agents.
View details for DOI 10.1016/j.kint.2025.12.014
View details for PubMedID 41455584